Targeted Metallo-Drugs

1699,-

Kjøp

<P>Volume 24, entitled <EM>Targeted Metallo-Drugs: Design, Development, and Modes of Action,</EM> of the series <EM>Metal Ions in Life Sciences </EM>(MILS), fosters inter-disciplinary research in the vibrant field of <I>Biological Inorganic Chemistry</I>. Inspired by the clinical success of cisplatin as a leading anticancer drug but mindful of the shortcomings associated with its use including dose-limiting toxic side effects and acquired or intrinsic drug resistance, scientists across the globe have been endeavoring to identify new metallo-drugs for therapeutic exploitation. This has led to innovative metallo-drug candidates that (i) enhance cancer cell selectivity, thus reducing toxic side effects, and/or (ii) possess new modes of action to improve efficacy and also target resistance pathways. This and more are captured in MILS- 24 which consists of 12 comprehensive, well-illustrated, and up to date chapters with over <B>1600 </B>citations, <B>100 </B>figures, and <B>10 </B>tables wi